The “Monthly Roundup” is a monthly newsletter dedicated to sharing the latest news from the Duke Global Health Innovation Center and Innovations in Healthcare. View the October 2024 newsletter. Subscribe to the monthly newsletter.
Welcome to the third installment of the Innovations in Healthcare Global Health Innovation Grantees blog series. History of the Global Health Innovation Grants Program Since 2016, The Pfizer Foundation’s Global Health Innovation Grants (GHIG) program has supported community-based initiatives that aim to improve quality of care and strengthen health systems in lower income countries. Innovations in Healthcare supports GHIG grantees by facilitating connections in the ecosystem, hosting GHIG-specific workshops and peer convenings at the Annual Forum, and conducting regular program monitoring to provide portfolio and individual results to the Pfizer Foundation. Now in its eighth year (GHIG8), 20 new recipients of the one-year grant program have each received $100,000 USD to drive innovative solutions that help address vaccine-preventable illness in their communities. [caption id="attachment_5800" align="aligncenter" width="596"] GHIG8 geographic scope. This year’s grantees address…
The COVID-19 pandemic exposed significant global inequities in the access to therapeutics, vaccines, testing, and other medical interventions that could limit the range and impact of the disease. These global inequities are not limited to the COVID-19 pandemic and need to be critically addressed in the ongoing mpox outbreak. Through Quickstart, we aim to serve as an external, independent source for tracking actions to meet commitments, catalyzing additional commitments to meet the need, and holding the world to account for the mpox response. Access the full report.
The “Monthly Roundup” is a monthly newsletter dedicated to sharing the latest news from the Duke Global Health Innovation Center and Innovations in Healthcare. View the September 2024 newsletter. Subscribe to the monthly newsletter.
Welcome to the second installment of the Innovations in Healthcare Global Health Innovation Grantees blog series. Access the first blog here. History of the Global Health Innovation Grants Program Since 2016, The Pfizer Foundation’s Global Health Innovation Grants (GHIG) program has supported community-based initiatives that aim to improve quality of care and strengthen health systems in lower income countries. Innovations in Healthcare supports GHIG grantees by facilitating connections, hosting program-specific workshops and peer convenings at the Annual Forum while also conducting regular program monitoring to provide portfolio and individual results to the Pfizer Foundation. Now in its eighth year (GHIG8), 20 new recipients have each received a USD $100,000 one-year grant to drive innovative solutions that help address vaccine-preventable illness in their communities. [caption id="attachment_5800" align="aligncenter" width="596"] GHIG8 geographic scope. This year’s grantees…
The “Monthly Roundup” is a monthly newsletter dedicated to sharing the latest news from the Duke Global Health Innovation Center and Innovations in Healthcare. View the August 2024 newsletter. Subscribe to the monthly newsletter.
The 2024-25 Global Health Innovation Grantees Blog Series 1 of 4, via Innovations in Healthcare History of the Global Health Innovation Grants Program Since 2016, The Pfizer Foundation’s Global Health Innovation Grants (GHIG) program has supported community-based initiatives that aim to improve quality of care and strengthen health systems in lower income countries. Innovations in Healthcare supports GHIG grantees by facilitating connections, hosting program-specific workshops and peer convenings at the Annual Forum while also conducting regular program monitoring to provide portfolio and individual results to the Pfizer Foundation. Now in its eighth year (GHIG8), 20 new recipients have each received a USD $100,000 one-year grant to drive innovative solutions that help address vaccine-preventable illness in their communities. [caption id="attachment_5800" align="aligncenter" width="596"] GHIG8 geographic scope. This year’s grantees address a range of infectious diseases…
The “Monthly Roundup” is a monthly newsletter dedicated to sharing the latest news from the Duke Global Health Innovation Center and Innovations in Healthcare. View the July 2024 newsletter. Subscribe to the monthly newsletter.
This newsletter aims to provide a central hub for information, milestones, and updates regarding the COVID Treatment QuickStart Consortium. The COVID Treatment QuickStart Consortium partners with governments to rapidly introduce and scale access to COVID-19 oral antiviral therapies in vulnerable and high-risk populations presenting with mild to moderate symptoms within five days of symptom onset through a public health test-and-treat model. QuickStart’s top priorities are: Ensuring treatments are accessible in all parts of the world; Preparing for potential future COVID-19 surges; and Building primary healthcare capacity for test-and-treat beyond COVID-19. View the July 2024 QuickStart newsletter. Subscribe to the QuickStart newsletter.
Market access to COVID-19 oral therapeutics in low- and middle-income (LMIC) countries was delayed. It took nearly fifteen months from the US FDA emergency use listing for nirmatrelvir/ritonavir to be delivered to the first LMIC countries by global buyers, long after the major COVID-19 waves had passed. Vaccines played a major role in managing the pandemic; next time the first line of defense may be therapeutics, reinforcing the need to identify key insights and develop recommendations that will hasten the process in future global emergencies. The QuickStart Consortium undertook a rapid policy analysis to understand global and national level factors that delayed market access to oral antivirals. The analysis established that significant but solvable challenges slowed down the time taken to get the oral antivirals to people when they needed…
